Details for New Drug Application (NDA): 214314
✉ Email this page to a colleague
NDA 214314 describes VASOPRESSIN, which is a drug marketed by Am Regent, Amneal, Amphastar Pharms Inc, Cipla, Dr Reddys, Eagle Pharms, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Baxter Hlthcare Corp, and Long Grove Pharms, and is included in eleven NDAs. It is available from nine suppliers. Additional details are available on the VASOPRESSIN profile page.
The generic ingredient in VASOPRESSIN is vasopressin. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the vasopressin profile page.
The generic ingredient in VASOPRESSIN is vasopressin. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the vasopressin profile page.
Summary for 214314
| Tradename: | VASOPRESSIN |
| Applicant: | Eugia Pharma |
| Ingredient: | vasopressin |
| Patents: | 0 |
Suppliers and Packaging for NDA: 214314
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VASOPRESSIN | vasopressin | SOLUTION;INTRAVENOUS | 214314 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1623 | 51662-1623-1 | 1 mL in 1 VIAL, MULTI-DOSE (51662-1623-1) |
| VASOPRESSIN | vasopressin | SOLUTION;INTRAVENOUS | 214314 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1623 | 51662-1623-2 | 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1623-2) / 1 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 20UNITS/ML (20UNITS/ML) | ||||
| Approval Date: | Aug 15, 2022 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
